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Executive Summary
Step Model for Managing Chronic, Non-Malignant Pain in Primary Care
Problem
Patients managed in primary care have more opportunity for aberrant behaviors due to the
additional time and resource requirements needed for careful monitoring and risk mitigation
(Veterans Administration, 2016). Not only do primary care providers lack the time to monitor
patients closely by random drug screening, checking the PDMP, and frequent appointments they
also lack sufficient training in medical and nursing schools to manage the chronic pain patients
(Lincoln, Pellico, Kerns, &Anderson, 2013). This project was selected due to the growing
opioid crisis. According to data from the Centers for Disease Control (CDC), from 1999 to
2015, more than 183,000 people died in the U.S. from overdoses related to prescription opioids
(CDC, 2017; Rudd, Puja, David & Scholl, 2016).
Purpose
Following a thorough literature review, the PICO question was: Will primary care providers who
prescribe opioids for chronic non-cancer pain provided with an education module and step model
for managing chronic, non-cancer pain improve their knowledge and confidence and utilize the
CDC guidelines in managing the chronic non-cancer patient as evidenced by reported
improvement in knowledge, confidence and improved prescribing practices compared to
knowledge, confidence, and prescribing practices before the education module and step model?
Goals
The project goal was to contribute to nursing practice by utilizing the CDC
recommendations to help with the opioid epidemic by identifying the educational gap for
primary care providers with respect to chronic pain management and thereby reducing the
number of inappropriately prescribed opioids by primary care.
Objective
This project sought to improve provider knowledge and confidence in managing chronic pain
patients in the primary care setting as well as improving utilization of the CDC guidelines for
managing chronic pain patients. This was a quality improvement project.
Plan
The study design was a quantitative pre-test-post-test design. The participating primary
care providers completed a pre-education assessment of their knowledge and confidence levels
managing chronic pain patients. After the providers completed the online education module and
had sufficient time to use the step model in treating chronic pain patients, they completed a postimplementation assessment on their knowledge and confidence levels for comparison, n=7.
Outcome, Results, and Recommendations
The intervention made a statistically significant difference in five of the seven questions.
Question one exhibited the most improvement (Z=21.00, p=.020) indicating a statistically
significant improvement in their knowledge managing chronic, non-malignant pain (CNMP) in
their primary care practice. This project can serve as the framework for additional research on
the step model with a larger sample size and more nurse practitioner participation.
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This doctoral project explored the problem recognition and definition, review of
evidence, project plan and evaluation, findings and results, limitations, recommendations, and
implications for change; improved knowledge and confidence of primary care providers in
managing chronic non-cancer pain.
Problem Recognition and Definition
Statement of Purpose
The National Institutes of Health Medline Plus (2011) defines chronic pain as “often
defined as any pain lasting more than 12 weeks. Whereas acute pain is a normal sensation that
alerts us to possible injury, chronic pain is very different. Chronic pain persists—often for
months or even longer…” (p.5-6). In 2015 report about the prevalence of chronic pain in the
United States (U.S.) from the National Center for Complimentary and Integrative Health “an
estimated 25.3 million adults (11.2 percent) experience chronic pain—that is, they had pain
every day for the preceding 3 months. Nearly 40 million adults (17.6 percent) experience severe
levels of pain…” (para. 1). According to an article by Daubresse et al. (2013) as cited on the
Centers for Disease Control (CDC) website,
From 2007 – 2012, the rate of opioid prescribing has steadily increased among specialists
more likely to manage acute and chronic pain. Prescribing rates are highest among pain
medicine (49%), surgery (37%), and physical medicine/rehabilitation (36%). However,
primary care providers account for about half of opioid pain relievers dispensed (CDC,
2016, para. 2).
According to data available from the CDC from 1999 to 2015, more than 183,000 people
have died in the U.S. from overdoses related to prescription opioids (CDC, 2017; Rudd, Puja,
David & Scholl, 2016). The purpose of this project was to provide training on the CDC
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guidelines for prescribing opioids for chronic pain as well as implementation of a step model for
primary care providers.
Problem Statement
Primary care providers are unprepared in medical and nursing schools to treat subacute
and chronic pain (Ponte & Johnson-Tribino, 2005). There are many non-opioid medications that
should be prescribed before opioid therapy is initiated (Dowell, Haegerich & Chou, 2016).
Many primary care providers (PCPs) need guidance when caring for chronic pain patients but
lack access to pain management specialists (Lincoln, Pellico, Kerns, &Anderson, 2013).
According to Lincoln, Pellico, Kerns, and Anderson (2013), “PCPs experience substantial
difficulties in caring for patients with pain while acknowledging certain positive aspects. There is
a need for strategies that mitigate the barriers to pain management while bolstering the positive
aspects to improve care and provider satisfaction” (p. 1).
PICO Question
This project utilized the acronym “PICO”, rather than stating a formal research
hypothesis. The acronym stands for: The population (P), intervention (I), comparison (C), and
outcome (O) and is usually framed as question (Melnyk & Fineout-Overhold, 2011). The
question for this project was as follows:
P: Primary care providers who prescribe opioids for chronic non-cancer pain
I: An education module and step model for managing chronic, non-cancer pain based on the CDC
guidelines
C: Knowledge, confidence, and prescribing practices compared to before the education module
and step model
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O: As evidenced by reported improvement in knowledge, confidence and improved prescribing
practices
Will primary care providers who prescribe opioids for chronic non-cancer pain who are
provided with an education module and step model for managing chronic, non-cancer pain
improve their knowledge and confidence in managing the chronic non-cancer patient as
evidenced by reported improvement in knowledge and confidence compared to knowledge and
confidence before the education module and step model?
The PICO question originates from and specifically relates to the role of the Doctor of
Nursing Practice (DNP) role as an advanced health care leader with the ability to integrate
objective data with the knowledge gained from a group’s subjective experience, as well as, the
ability to apply scientific knowledge to the processes of program development, management, and
evaluation (Chism, 2010).
Significance, Scope, and Rational
This is a quality improvement project aimed to yield several outputs. First, this project
sought to improve provider knowledge and confidence in managing chronic pain patients in the
primary care setting. Secondly, chronic pain patients will be managed using CDC guidelines
improving patient outcomes. Finally, there will be a decrease in inappropriately prescribed
opioids by primary care providers that will result in a decrease in overall pill burden in
community and decrease nonmedical use of opioids.
Theoretical Foundation
Advanced practice nurses use knowledge from a variety of domains allowing nursing
practice to develop a full, rich body of knowledge. According to Zaccagnini and White (2017)
nursing uses knowledge from many domains including biology, physiology, zoology, medicine,
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psychology, sociology, physics, mathematics, chemistry, communication, philosophy, and
theology (p.4). By utilizing a wide breadth of knowledge, nurses are able to develop knowledge
that informs nursing practice with a very holistic approach. The scientific underpinnings of
nursing knowledge are based on the way nurses view the world as well as how nurses view
patient care.
There are several domains that make up the scientific foundations of nursing. First, the
philosophical foundation is the base on which nursing knowledge is built. There are different
philosophical views but according to Burns and Grove (2001) there are several themes common
to the nursing profession; holism, quality of life, and the relativity of truth based on each
person’s perspective. Zaccagnini and White (2017) other fundamental foundations include
ethical knowledge, historical knowledge, biophysical and psychosocial knowledge, analytical
knowledge, and organizational knowledge.
Scientific research and nursing research is guided by a framework. This framework
provides the researcher with “the base from which we seek to understand patients and their
health problems and from which we plan interventions to help them” (Zaccagnini & White,
2017, p. 14). Nursing theory helps the researcher produce higher quality work by providing the
framework from which we develop a “systematic way to explain or describe nursing practice”
(Zaccagnini & White, 2017, p. 15). According to Association of Critical-Care Nurses (AACN),
“The DNP graduate knows how to integrate nursing science with knowledge from ethics, the
biophysical, psychosocial, analytical, and organizational sciences as the basis for the highest
level of nursing practice” (AACN, 2006, p. 9).
The Synergy Theory was developed by the American Association of Critical-Care Nurses
(AACN) credentialing arm to better describe nursing practice in 1998. The Synergy Model
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describes what nurses do, thus this theory describes the essence of nursing; namely nurses
undertaking what the patient needs them to do. The fundamental premise of the theory is
“patient characteristics drive nurse competencies. When patient characteristics and nurse
competencies are in synergy, optimal patient outcomes are more apt to occur…” (Curley, 2007,
p. 25).
The Synergy Model is a middle range nursing theory. The theory describes eight patient
characteristics and eight nurse competencies. The patient characteristics that span the continuum
from health to illness are stability, complexity, vulnerability, predictability, resiliency,
participation in decision-making, and resource availability (Curley, 2007). The nursing
dimensions span from competent to expert are clinical judgment and inquiry, caring practices,
response to diversity, advocacy/moral agency, facilitation of learning, collaboration, and systems
thinking (Curley, 2007). The model proposes optimal patient outcomes occur when the patient
and the nurse synergize. The theory requires three levels of outcomes, nurse outcomes, patient
outcomes, and system outcomes (Curley, 2007).
There are four assumptions in the synergy model. First, a holistic view of the person is
used; mind, body, and spirit. Second, nurse patient interactions affect each dimension. Third all
dimensions are considered collectively. And finally, the goal of nursing is to restore the patient
to health. The underlying tenants are “patient characteristics are important to nurses, nurses’
competencies are important to patients, patient characteristics drive nurse competencies, and
when patient characteristics and nurses’ competencies match and synergize, outcomes for the
patient are optimal” (Kaplow & Reed, 2008).
All of the concepts of the theory are theoretically and operationally defined in, Synergy,
The Unique Relationship Between Nurses and Patients, the AACN Synergy Model for Patient
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Care by Martha A. Q. Curley (2007). The theory is extensively and meticulously defined, and
examples of outcomes are presented for patient/family, unit, and systems-level outcomes. The
theory statements are theoretically and operationally defined. The linkages are explicit and clear.
The model diagram adds to the clarity of the theory. The major concepts are represented in the
model. The concepts, statements, and assumptions are all used consistently and appropriately in
the body of text. The outcomes are predicted based on the context of the interactions.
The theory is congruent with current nursing standards. It is a widely utilized theory and
utilized as the model of AACN certification testing. The theory is congruent with current
nursing interventions. The model is used for patient care in outpatient and inpatient settings,
professional nursing, staff development, system building, and nursing education. The model has
been widely used for nursing practice, research, and education. In a study by Cypress (2013) the
model was used to conceptualize the data and served as the framework to recommend practice
improvements for patients in the emergency room. This is well researched and vetted theory
useful for many different areas of research, education, and nursing practice.
The theory is socially relevant to patients/individuals and families regardless of gender,
age, or socioeconomic status. The theory has transcultural relevance because it explores the
relationship between the nurse and the patient irrespective of culture.
This theory is appropriate to serve as the theoretical framework of this project for several
reasons. First, it was used to describe the relationship between the chronic pain patient and the
advanced practice nurse, thereby helping to guide practice improvement. Secondly, the theory
informed the project and helped develop the step model. Finally, the book authored by Martha
Curley is very detailed and informative about how to use the model in a variety of different
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settings such as an ambulatory clinic, as well as nursing practice, patient care, and even within a
healthcare system. The theory was informative in most areas of the project.
Figure 1: Synergy Theory (Curley, 2007)
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The second theory to inform this study was the Lewin Change Theory which was
developed by Kurt Lewin in the 1940’s. This is a three-stage change model, unfreezing, change,
refreeze. Lewin viewed change behavior as a “dynamic balance of forces working in opposing
directions” (Kritsonis, 2005, p. 1). The model requires prior learning to be rejected and replaced
(Petiprin, 2016).
There are three major concepts, driving forces, restraining forces, and equilibrium.
Driving forces are forces facilitating change. Restraining forces are forces that counter the
driving forces and hider change because they push in the opposite direction. Equilibrium is a
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state in which driving forces equal restraining forces to maintain stability and no further changes
occur (Petiprin, 2016).
Unfreezing is the process in which an intervention makes it possible for people to change
an old counterproductive pattern (Petiprin, 2016). Change, which is also called movement to a
new level, involves a process with change in thoughts, feelings, behaviors, or all three to a more
productive state (Petiprin, 2016). Refreezing stage establishes the change with a new norm, or
the new standard (Petiprin, 2016).
Review of Evidence
Systematic Review
The literature review was performed using the databases CINAHL, Google Scholar,
Cochrane Database, and PubMed. The initial search reference time frame was August 2016 to
February 2017. The key words of opioid, chronic pain management, primary care, pain
management guideline, provider attitude and provider were used. The level of evidence was
determined by utilizing a grading system developed by Ackley, Swan, Ladwig and Tucker
(2008) (figure 2). Inclusion criteria were limited to studies in English available electronically
and limited to the past five years. After reviewing abstracts, articles were excluded if they did
not contain clear recommendations for pain management or were not related to primary care
providers and pain management. Many articles were found using data mining.
The initial searches produced large quantities of literature. Each was narrowed
down using Boolean phrases as well as the inclusion criteria listed previously. The key word
opioid was searched using Google Scholar yielding 48,400 results, opioid guidance yielded
22,800 results, and chronic pain yielded 17,100 results. Primary care attitudes and beliefs about
opioids yielded 5,530 results, primary care attitudes and beliefs about chronic pain management
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yielded 6,060 results; opioid step model yielded 17,200 results and opioid stepped care model
yielded 1,710 results. Of those searches only three articles were used. The search in Google
Scholar yielded many articles not relevant to this project.
Figure 2: Literature Grading System

Level of Evidence (LOE)

Description

Level I

Evidence from a systematic review or meta-analysis
of all relevant RCTs (randomized controlled trial) or
evidence-based clinical practice guidelines based on
systematic reviews of RCTs or three or more RCTs of
good quality that have similar results.

Level II

Level Ill

Level IV

Level V

Level VI
Level VII

Evidence obtained from at least one well-designed
RCT (e .g. large multi-site RCT).
Evidence obtained from well-designed controlled
trials without randomization (i.e. quasi-experimental).
Evidence from well-designed case-control or cohort
studies.
Evidence from systematic reviews of descriptive and
qualitative studies (meta-synthesis).
Evidence from a single descriptive or qualitative
study.
Evidence from the opinion of authorities and/or
reports of expert committees.

The key word chronic pain was searched using CINHAL yielding 38,914 results, chronic
pain management yielded 7,341 results, chronic pain guideline yielded 647 results, opioids
yielded 23,589 results, opioid guideline yielded 1,360 results, pain management yielded 305
results, primary care provider plus chronic pain yielded 21 results, primary care provider plus
chronic pain plus opioid guideline yielded only three results. A total of 23 publications were
used from the CINHAL database.
The key word chronic pain was searched in PUBMED yielding 1,213 results, chronic
pain management plus opioid guideline yielded 31 results, chronic pain and primary care yielded
2,016 results, chronic pain plus primary care plus opioid yielded 302 results and chronic pain
plus primary care plus opioid plus guideline yielded 65 results. A total of eight publications
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were used from the PUBMED database. Overall, a total of 34 articles were used to inform this
project as listed in table one.
Table 1: Levels of Evidence

Levels of Evidence

# articles

Level 1

12

Level 2

2

Level 3

0

Level 4

8

Level 5

2

Level 6

2

Level 7

8

Evidence and Background
After a thorough literature review, several themes were identified. These themes
included: close monitoring, clinical practice guidelines, safeguards, barriers, Prescription Drug
Monitoring Program, drug testing, and education of providers about pain management (see
Appendix A: Systematic Review of Literature Sample).
Ponte and Johnson-Tribino (2005) identified several barriers to managing chronic pain
patients. They recognized that caring for pain patients was time consuming and frustrating,
physicians were fearful of patient harm and scrutiny from regulatory agencies, knowledge gaps,
and formal medical training did not prepare them to manage pain effectively. The authors
concluded the results should be used to expand education for students and practicing providers.
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Dorflinger et al. (2014) suggested primary care providers use a step model for chronic
pain treatment help to lower opioid use and increase the use of non-opioid medications, as well
as the use of complementary approaches to pain management. The research occurred in the
Veterans’ Administration (VA) Health System and only used electronic health records utilized in
the VA system however; it illustrates the effectiveness of the intervention and the potential
usefulness for other populations. There were no similar studies found that utilized a step model
for managing chronic pain in the civilian population which highlighted a gap in the literature.
It is very difficult for a primary care provider to properly monitor a patient who is being
prescribed opioids. Their time is very limited for each patient and when they are faced with a
patient who has complaints of severe, chronic pain they naturally want to help. According to
McCrorie et al. (2015), “Problematic prescribing occurs when patients experience repeated
consultations that do not meet their needs and GPs [General Practitioners] feel unable to
negotiate alternative approaches to treatment” (p.1). Without proper monitoring of pain
patients, it can lead to diversion or addiction. On the other hand, fear of prescribing pain
medication can leave the patient with untreated pain. According to Daubresse et al. (2013)
primary care providers accounted for almost half of opioid pain medications dispensed. They
also noted during the years 2000-2010, although prescribing of opioids increased, a similar
increase in non-opioid medications was not noted.
Vijayaraghavan, Penko, Guzman, Miaskowski and Kushel (2012) looked at primary care
providers (PCP) views on chronic pain among high-risk patients, PCPs “reported low confidence
and satisfaction levels in treating chronic pain” (p.1141). The study results exposed that PCPs
are likely to prescribe opioids to current illicit substance abuse patients, highlighting their lack of
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knowledge concerning opioid therapy. The low confidence scores and lack of adequate
education put patients’ lives and the providers’ licenses in danger.
In a qualitative analysis by Lincoln, Pellico, Kerns, and Anderson (2013) looking at the
barriers and facilitators to chronic non-cancer pain management in primary care provider’s
experiences and attitudes, 11 themes were identified. One of the barriers included inadequate
training. Providers who do not feel confident either avoid managing CNMP or may
inappropriately manage these patients.
Finally, Ponte and Johnson-Tribino (2005) looked at the attitudes and knowledge about
pain in West Virginia Family Physicians, “The majority of respondents felt that their formal
medical training did not prepare them to effectively manage pain” (p. 477). These articles
provide insight into why there is such wide variation in provider attitudes about pain
management and the inconsistencies in managing chronic pain.
Patients who experience acute pain are often treated first by their primary care providers
(Lincoln, Pellico, Kerns, &Anderson, 2013). The pain may be related to recent surgery, injury,
or disease. There are many factors contributing to the phenomena of opioid misuse. Often the
patients are either undertreated due to provider fear of patient drug addiction and/or lack of
understanding and fear of federal regulations regarding the prescribing of pain medications
(Ponte & Johnson-Tribino, 2005). Conversely, patients may be over-treated due to insufficient
knowledge of treating pain and lack of evidenced based practice guidelines regarding treatment
of CNMP (Ponte & Johnson-Tribino, 2005).
Project Plan and Evaluation
Market/Risk Analyses
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A full market/risk analysis was performed for this project including identifying strengths,
weaknesses, opportunities and threats in the form of a SWOT analysis (strengths, weakness,
opportunities, threats). A SWOT analysis helps the researcher discover and utilize strengths and
to control and reduce or eliminate weaknesses if possible. Additionally, there was a full analysis
of the driving and restraining forces.
Project strengths, weaknesses, opportunities, threats (SWOT)
When considering the strengths, weaknesses, opportunities, and threats related to this
project, there are several things contemplated. There are several strengths associated with this
project. First, this is a subject of great concern and very relevant at this time. This project was a
practice improvement project with the potential to directly impact the opioid epidemic in a
positive manner. Also, there was very little cost associated with this project. The costs consist of
time and minimal recourses such as paper and ink. The research team consisted of committed
and collaborative members. The major weakness of this project was the time commitment. The
time commitment was great, and the project was implemented while the DNP student was
working full time. Further, the expert collaborators and mentor also maintained full time
employment. Additionally, there was the potential lack of stakeholder buy-in.
The opportunities of this project include the fact this is a timely project and the Centura
Health System reached out to the DNP student about this project. There is a potential
opportunity of having this project published in a professional journal and the potential for
additional research of the step model. Finally, the threats to this project were the potential lack
of participation of primary care providers and a limited sample size.
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Table 2: SWOT Analysis of Capstone Project
Strengths
•

Timely, relevant topic

•

Practice improvement

•

Evidenced based interventions

•

Low cost

•

Research team

•

Potential for practice improvement

Weakness
•

mentor
•

Opportunities
•

•

Time commitment DNP student and

Potential lack of stakeholder buy-in

Threats

Centura Health System interest in

•

Provider participation

project

•

Limited sample size

Potential publication in a
professional journal

•

Potential for additional research of
step model

Driving/Restraining Forces
This project had a time line adhered to in order to meet the requirements and deadlines
set forth by the Regis University DNP program (see Appendix B: Timeline). This was a driving
force for this project. The restraining force was the time commitment as well as provider
participation. Finally, the sustaining force was the collaboration of the DNP student and the
mentor as well as the deadlines set by Regis University. The DNP student and the mentor met
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regularly to discuss the project keeping it on a forward trajectory. The due dates helped keep the
project moving forward at an anticipated pace.
Stakeholders and Project Team
The stakeholders of this project included Centura Health Systems, primary care
providers, as well as patients. The benefit of having a tool easily accessible and easily
comprehended will help with evidenced based management of chronic pain. Additionally, by
utilizing evidenced based guidelines easy to access and apply should decrease the number of
opioids prescribed (Doreflinger et al., 2014). Further, the mentor for this project was contacted
by the State of Colorado Public Health Department to develop a training module for chronic pain
management. If successful, this project could potentially be used for this purpose.
The project team consists of the DNP student the mentor, Bonnie Wilensky, CNS. Bonnie
has over 40 years of experience in pain management. She is considered to be an expert in her
field. She has been asked to speak on many occasions for peer to peer trainings as well as
speaking for pharmaceutical companies about pain management. She has been an expert witness
for the Colorado State Board of Nursing.
The DNP student and the mentor were responsible for development and implementation
of the project including the step model and educational module. They were also responsible for
developing the evaluation tool. Other members of the team include practicing pain management
providers, Dr. Leif Sorensen, Dr. Bryan Wernick, and Tina Snyder, DNPc. They were
responsible for reviewing the step model and educational module and making recommendations
before implementation and establishing validity. The DNP capstone Chair, Cris Finn, PhD, FNP
worked with the pain management team.
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Cost-benefit Analysis
The cost of this project was nominal. Since the project team based the step model and
educational module from the CDC guidelines there was very little cost involved other than time.
The CDC gave permission for the utilization of the guidelines. There was the cost of coping
(estimated at 10 cents per page) and purchasing a storage box with locks ($50). The equipment
needed to produce the educational module is Power Point software and a computer, which was
already owned by the DNP student. The potential benefits of the project far outweigh the
minimal costs (see Appendix C: Budget).
The benefit analysis is difficult to determine on a per patient basis. However, the cost of
the opioid epidemic is astronomical. The health and social costs of opioid abuse is
approximately $55 billion each year in the United States (HHS, 2016). The cost of emergency
department and inpatient treatment is approximately $20 billion per year in the United States
(HHS, 2016). Most importantly, the benefit of this project is the potential to reduce the number
of lives lost each year to opioid poisonings. In 2015 in Colorado, 259 people died from
prescription opioid overdoses. That means that in 2015 approximately one Coloradan died every
36 hours from and opioid overdose (Colorado Department of Healthcare Policy and Finance,
2017). There is some good news for Colorado, the number of opioid overdose deaths decreased
6% in 2016 (Colorado Department of Healthcare Policy and Finance, 2017). However, heroin
overdose deaths increased 23% in 2016 (Colorado Department of Healthcare Policy and Finance,
2017). How can we put a cost on the value of an abuse free life? Priceless.
Mission/Vision/Goals
The mission of this project was to provide education and easily accessible and
comprehensible guidance for primary care providers in managing chronic, non-cancer pain
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utilizing the newly updated CDC guidelines. The vision of the project is to improve provider
satisfaction in caring for patients with chronic, non-cancer pain as well as improving patient
outcomes by utilizing best practices.
According to Terry (2015), the DNP “applies knowledge in the solution of a problem…”
(p. 16). The proposed project utilized scholarly works and evidenced based practice
recommendations to help solve the problem of primary care providers’ decreased knowledge and
confidence to manage chronic pain patients. The goal of this project was to increase provider
knowledge and confidence with the implementation of the step model and the education module
and ultimately evidence to support a need for increased education in pain management for nurse
practitioners and physicians as the providers.
The DNP aimed to contribute to nursing practice by utilizing evidenced based practice
recommendations to help with the opioid epidemic by identifying the education gap for primary
care providers with respect to chronic pain management and thereby reducing the number of
opioids prescribed by primary care. Vijayaraghavan, Penko, Guzman, Miaskowski, and Kushel
(2012) demonstrate PCP lack of confidence with pain management and need for intervention.
The authors suggest developing a similar model to the VA model of pain management. Lincoln,
Pellico, Kerns, and Anderson (2013) richly describe several themes related to provider views on
pain management. The authors discuss inadequacy of education and lack of evidenced based
guidelines to be used for treatment supporting a gap in the literature.
Process/Outcomes
A step model was developed which was easy to follow and available for quick reference
(Figure 3: Step Model). Additionally, there was also an online training video for primary care
providers to access produced by the CDC (see Appendix D: CDC Education Modules). The
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project outcomes were improved knowledge and confidence for primary care providers
managing chronic pain patients, increased understanding and utilization of the CDC guidelines,
increased provider satisfaction when managing chronic pain patients in the primary care setting,
and a decrease in the overall prescribed opioids by each provider. The Step model was sent to
Dr. Deborah Dowell at the CDC who offered updates and approval for utilization (see Appendix
E: CDC Response).
Figure 3: Step Model
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Logic Model
According to the W.K. Kellogg Foundation Logic Model Guide (2004) the logic model
“and its processes facilitate thinking, planning, and communications about program objectives
and actual accomplishments” (p.III). The logic model helps the researcher focus on the specific
areas of planning, design, implementation, analysis, and outcomes (W.K. Kellogg Foundation,
2004). The W.K. Kellogg Foundation defines a logic model as “a systematic and visual way to
present and share your understanding of the relationships among the resources you have to
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operate your program, the activities you plan, and the changes or results you hope to achieve”
(W.K. Kellogg Foundation, 2004, p. 1) (see Appendix F: Conceptual Model).
Through the use of the logic model, key elements of the project were evaluated. There
were several considerations to be addressed to accomplish the goals for this project. The first
step was to identify needed resources. For this project that included identifying evidenced based
practice guidelines for managing chronic pain. The CDC developed a comprehensive guideline
for managing chronic pain (MMRW, 2016) a step model and an education module was
developed based on those CDC guidelines (Figure 3: Step Model).
There were several constraints for this project. The first constraint was the willingness of
primary care providers to participate in the study. In order for the study to be meaningful, the
study required at least 20 participants which was the total available population of primary care
providers in the research site. Centura needed to approve the study, be willing to participate, and
obtain Institutional Review Board (IRB) approval through the Catholic Health Initiative.
Additionally, the current attitudes and practices of primary care providers may influence their
willingness to participate.
Next, the constraints and activities to benchmark targets were identified. The expected
outcomes were improved provider knowledge and confidence, improved patient outcomes, and a
decrease in inappropriately prescribed opioids thereby increasing patient and community safety.
There were several expected short- and long-term outcomes. First, create a decrease in the
overall pill burden in the community as well a decrease in nonmedical use of opioids. Over the
course of one to three years, the goal is for the step model and education module to be
implemented in the surrounding communities with state-wide implementation within four to six
years. The long-term impact of the project is to illuminate the need to implement focused

education on chronic pain management in the primary care setting for nurse practitioners and
physicians. The ultimate goal of the project is to reduce opioid misuse and impact the opioid
epidemic.

Assumptions

Inputs

Activities

Outputs

Outcomes

Impact

Evaluation Logic Model Guide, W.K. Kellogg Foundation, Page 12

Figure 4: Logic Model (format depicting Conceptual Model for project)
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Population/Sampling/Setting
In order to define the number of providers needed to determine if the intervention
produces the expected effect, a power analysis was performed. Using a calculator from National
Statistical Service (2017), it was determined to obtain a 95% confidence level with a 0.05
confidence interval, with an available population of 20 primary care providers, 19 primary care
providers was required to achieve a 0.80 power. This will also help to minimize the threat of a
Type I and Type II errors. However, using the total available population was ideal. A type I
error for this project would be to make a false positive conclusion that the intervention resulted
in a statistically significant improvement due to sampling fluctuations. A type II error would be
a false negative conclusion preventing the implementation of the step model and education
module.
According to the World Health Organization (WHO) and the University of Amsterdam
the sample size for a descriptive study “needs to be large enough to reflect important variations
in the population, but small enough to allow for intensive study methods” (World Health
Organization, 2004, p. 65). Having a sample of at least 20 primary care providers was large
enough to accurately assess the step model using quantitative methods. Further, since there was
limited access to primary care providers, the sample size needed to be small.
The sample size needed for quantitative data generally requires a larger sample size. In
order to obtain a 95% confidence level with a 5% margin of error, the total available population
of primary care providers should be used. According to Terry (2015) the best course of action is
to use the entire accessible population since it is under 100. Participants were recruited through
a presentation to primary care providers at a hospital in Denver, Colorado. The setting of the
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project was in primary care practices in the Centura Health system.
Protection of Human Subjects
The responsibilities of an investigator are to insure all ethical and legal considerations are
considered before implementing a research study. “It is the responsibility of each investigator to
seek review by the IRB for any study involving human subjects prior to beginning the project…”
(Regis University, 2015, p.5). The IRB not only protects the human subjects, but also protects
the researcher from making ethical errors. Regis University’s (RU) policy on using human
participants’ states:
Projects such as program evaluation, policy analysis, or quality assurance studies
conducted for the purpose of providing information only to the organization studied do
not require IRB review, provided they meet the following conditions: (1) They are not
intended to produce knowledge that contributes to the general base of human knowledge
or publishable; (2) They involve no more than minimal risk as defined in Federal
regulations and RU policy; (3) They do not involve vulnerable populations (Regis
University, 2015, p. 5).
According to RU policy, the study was considered a quality improvement project, and
therefore exempts status through the IRB (see Appendix G: Regis University IRB Exemption
Letter). The study was also awarded exempt status from Centura Health/Catholic Health
Initiatives (see Appendix H: Catholic Health Initiative IRB Exemption Letter).
Additionally, the pre-and post-tests were de-identified and given an assigned number to
match the pre-test to the post-test. The key was kept on a password protected computer and the
completed tests are kept in a locked file cabinet for three years after the completion of the project
per Regis guidelines (see Appendix I: CITI Certificates).
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Instrumentation Reliability/Validity and Intended Statistics
This project used data from a Likert scale, which is ordinal data, obtained from pre-test
and post-test (intervention) questionnaires from the same participants (see Appendices J: Pre-test
Questionnaire and K: Post-test Questionnaire) . The data was evaluated using Wilcoxon Signed
Ranks Test. This allowed the data from both groups to be paired for comparison linked by preassigned identifiers. Arifin (2014) states the goal for pre-post studies is “to determine whether
there is any significant difference or change in values for a particular numerical variable between
two occasions for same subjects” (p. e62). By analyzing the data with the Wilcoxon Signed
Ranks Test it can be determined if the education module and step model were effective in
increasing knowledge and confidence of each provider and as a group in managing chronic pain
patients in the primary care setting. To measure changing prescribing patterns and practices,
true/false questions were utilized, which is nominal data. This data was evaluated using
descriptive statistics.
There are several potential threats to validity and reliability that must be addressed. In a
pre- and post-test study, the threats to internal validity include selection, maturation,
mortality/attrition, history, testing, and instrumentation. Internal validity ensures the
independent variable caused the change in the dependent variable, meaning the education
module and step model caused a change in the knowledge and confidence of primary providers
caring for patients with CNCP.
When analyzing the data, one thing that must be considered is the possibility other events
effected the change in the dependent variable other than the independent variable, which is the
history effect (Polit & Beck, 2017). By choosing primary care practices in one hospital system,
it will be easier to monitor for other influencing factors such as required education. Further, the
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time between pre- and post-test was only four to six weeks to limit exposure to other influencing
factors. To control for maturation, which is the change in the dependent variable due to normal
developmental process, the pre-test Likert scale will determine each individual provider’s
knowledge and comfort level managing chronic pain patients prior to the intervention (Polit &
Beck, 2017). The same providers were included in the pre- and post-test and there was not a
control group which will avoid selection bias (Polit & Beck, 2017). To control for testing bias
the pre- and post-test were the same and to control for instrumentation bias a validated Likert
scale for the pre- and post-test was used (Polit & Beck, 2017).
External validity refers to the degree to which the results of a study can be generalized
across populations. To control for this, primary care providers from several different practices
who see a variety of patients should be included in the study (Polit & Beck, 2017). Additionally,
the Step Method was reviewed and approved by the CDC (see Appendix E: CDC Response).
If there is missing or incomplete data, it was acknowledged in the study where limitations
are discussed. Available data was analyzed and excluded any missing or incomplete data. There
were no call backs. This is not a blinded study and therefore, not tied to the individual
participant.
A data dictionary with all definable data elements was developed. The dictionary
explained the contents of the context-specific database. According to American Health
Information Management Association (AHIMA 2012), “…lack of data consistency can create
challenges for data comparison and reporting” (p.48). For these reasons, a table of data
definitions is included (see Appendix L: Data Dictionary).
Data Collection/Treatment Procedure
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Participants were recruited via direct contact at a provider meeting at a Denver hospital.
Project details and rationale were given to the attendees along with instructions for participation.
Packets with project materials including informed consent were provided for all interested
providers. A recruitment flyer was also displayed in the Denver area hospital (see Appendix M:
Recruitment Flyer).
The participants were given the informed consent, pre- and post-test, step model,
education, and module instructions in a self-addressed interoffice mail envelope. Reminder
emails were sent mid-February to encourage the participants to continue using the step model
and to complete the pre-test, consent, and watch the education modules if they had not already
done so. They were returned at the end of February through mid-March through interoffice
mail. The Likert Scale and true/false questions were developed using the steps described in
Nursing Research: Generating and Assessing Evidence for Nursing Practice by Polit and Beck,
2017. The items included were subjected to internal review by the DNP student and subject
matter expert mentor. The items were also evaluated by members of the target population,
primary care providers. Items were subjected to review by the expert consulting team to ensure
validity. Finally, the reliability of the items was verified using Cronbach’s alpha.
Project Findings and Results
Data Analysis and Results
There were 22 primary care providers who initially agreed to participate in the project
and of those, there were eight pre-tests returned and seven post-tests returned. The demographic
data was collected on the pre-test. For data analysis, the missing data was not included. 100%
of the participants were physicians (Table 3: Participant Education). The most represented age
group of the study participants was between 21 and 30 years (n=7) (Table 4: Participant
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Age). Additionally, 85.7% of the participants were female (Table 5: Participant Gender). The
pre-test and post-test consisted of 7 items that could be directly compared. Again, one case was
missing so it was excluded in the data analysis. Cronbach’s Alpha for the 7 items was (α = .892)
(Table 6: Cronbach’s Alpha Score). The pre- and post-test were found to be highly reliable.
Table 3: Participant Education
Education

Valid MD

Frequenc
y
Percent
7
100.0

Valid
Cumulative
Percent
Percent
100.0
100.0

Table 4: Participant Age
Age

Valid 21-30
31-40
41-50
Total

Frequenc
y
Percent
4
57.1
2
28.6
1
14.3
7
100.0

Valid
Cumulative
Percent
Percent
57.1
57.1
28.6
85.7
14.3
100.0
100.0

Table 5: Participant Gender
Gender
Frequenc
y
Percent
Valid male
1
14.3
female
6
85.7
Total
7
100.0

Valid
Cumulative
Percent
Percent
14.3
14.3
85.7
100.0
100.0
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Table 6: Cronbach’s Alpha Score
Reliability Statistics
Cronbach's
N of
Alpha
Items
.892
14
Results
Analysis of the first seven questions of the pre- and post-test was analyzed using the
Wilcoxon Signed-Ranks Test. The participants could choose (1) strongly disagree, (2) disagree,
(3) uncertain, (4) agree, or (5) strongly agree. They indicated their choice by checking a
corresponding box. For these questions n=7. One post-test score was missing and excluded in
the analysis. An alpha level of .05 was used for all statistical tests.
Question one stated: I have sufficient knowledge to manage chronic, non-malignant pain
(CNMP) in my primary care practice. The Wilcoxon Signed-Ranks Test indicated post-test ranks
were statistically significantly higher than the pre-test ranks (Z=21.00, p=.020) for question one
indicating provider’s perceived knowledge improved after the intervention (Table 7: Wilcoxon
Question 1). Analysis of the pre-test descriptive statistics indicated 42.9% were uncertain if they
had sufficient knowledge to manage chronic, non-malignant pain, 42.9% agreed they had
sufficient knowledge, and 14.3% felt they did not have sufficient knowledge (Table 8: Pre-test
Question 1). Post-test analysis displays 71.4% agreed they had sufficient knowledge to manage
chronic non-malignant pain and 28.6% strongly agreed (Table 9: Post-test Question 1).

28
Table 7: Wilcoxon Question 1
I have sufficient knowledge to manage chronic, non-malignant pain (CNMP) in my primary care
practice.
Related - Samples Wilcoxon Signed Rank Test
□ ri~i~r Differences

S.D

■ Negative Differences
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(~Nu~6er of Tie s "' 1)

>-

~ 3.0

~

u..

2.0

1.0,- +-------<

o.o,-+---~--+--~----,e--~----1
.OD
.so
1.00
1.50
2.00
2.50
3.00
Posttest qu estion 1 - Pretest question I

Total N

7

Test Statistic

21.000

Standard Error

4.500

Standardized Tes t Statistic

2.333

Asymptotic Sig. (2 - sided test)

.020

Table 8: Pre-test Question 1
I have sufficient knowledge to manage chronic, non-malignant pain (CNMP) in my primary care
practice.
Pre-test question 1

Valid

disagree
uncertain
agree
Total

Frequency
1

Percent
14.3

Valid Percent
14.3

Cumulative
Percent
14.3

3

42.9

42.9

57.1

3
7

42.9
100.0

42.9
100.0

100.0
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Table 9: Post-test Question 1
I have sufficient knowledge to manage chronic, non-malignant pain (CNMP) in my primary care
practice.
Post-test question 1

Valid

agree
strongly agree

Frequency
5

Percent
71.4

Valid Percent
71.4

Cumulative
Percent
71.4

2

28.6

28.6

100.0

7

100.0

100.0

Total

Question two states: I have access to education regarding how to manage opioids for
CNMP. The Wilcoxon Signed-Ranks Test indicated post-test ranks were not statistically
significantly higher than the pre-test ranks (Z=10.000, p=.066) for question two which indicated
there was no difference in access education between the pre- and post-test scores (Table 10:
Wilcoxon Question 2).
Descriptive statistical analysis of pre-test scores indicated 28.6% disagree, in other
words, they felt they did not have access to education, 14.3% were uncertain if they had access to
education, and 57.1% agreed they had access to education regarding how to manage opioids for
CNMP (Table 11: Pre-test Question 2).
Descriptive statistical analysis of post-test scores displayed 71.4% agreed they had access
to education regarding how to manage opioids for CNMP and 28.6% strongly agreed. Although
the improvement was not statistically significant, it was a positive improvement nonetheless
from a clinical perspective. Pre-test scores indicated 42.9% disagreed or were uncertain, posttest scores highlighted that all the participants felt they had access to education regarding how to
manage opioids for CNMP (Table 12: Post-test Question 2).
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Table 10: Wilcoxon Question 2
I have access to education regarding how to manage opioids for CNMP.

Related - Samp les Wilcoxon Signed Rank Test
□ Positive Differences
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■ Negative Differences
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4.00

7

Total N
Test Statistic

10.000

Standard Error

2.716

Standardized Test Statistic

l.841

Asymptotic Sig. (2 - sided test)

.066

Table 11: Pre-test Question 2
I have access to education regarding how to manage opioids for CNMP.
Pre-test question 2
Frequency
Valid

Valid Percent
28.6

Cumulative
Percent
28.6

disagree
uncertain

2

Percent
28.6

1

14.3

14.3

42.9

agree
Total

4
7

57.1
100.0

57.1
100.0

100.0
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Table 12: Post-test Question 2
I have access to education regarding how to manage opioids for CNMP.
Post-test question 2

Valid

agree
strongly agree
Total

Frequency
5

Percent
71.4

Valid Percent
71.4

Cumulative
Percent
71.4

2

28.6

28.6

100.0

7

100.0

100.0

Question three states: I have confidence in my ability to manage CNMP in primary care.
The Wilcoxon Signed-Ranks Test indicated that post-test ranks were statistically significantly
higher than the pre-test ranks (Z=10.000, p=.034) for question three which indicates the
participants confidence in their ability to manage chronic non-malignant pain improved after the
intervention (Table 13: Wilcoxon Question 3).
Descriptive statistical analysis of pre-test scores indicated 87.5% felt a lack of confidence
in their ability to manage CNMP and 14.3% had confidence in their ability to manage CNMP in
primary care (Table 14: Pre-test Question 3). Descriptive statistical analysis of post-test scores
displayed 28.6% were uncertain of their confidence in their ability to manage CNMP, 42.9%
agreed and 28.6% strongly agreed they had confidence in their ability to manage CNMP (Table
15: Post-test Question 3).
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Table 13: Wilcoxon Question 3
I have confidence in my ability to manage CNMP in primary care.
Relate d - Samples Wilco xo n Signed Rank Test
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.034
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Table 14: Pre-test Question 3
I have confidence in my ability to manage CNMP in primary care.
Pre-test question 3
Frequency
Valid

uncertain

Percent

Valid Percent

Cumulative
Percent

6

85.7

85.7

85.7

agree

1

14.3

14.3

100.0

Total

7

100.0

100.0
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Table 15: Post-test Question 3
I have confidence in my ability to manage CNMP in primary care.
Post-test question 3
Frequency
Valid

Percent

Valid Percent

Cumulative
Percent

uncertain

2

28.6

28.6

28.6

agree

3

42.9

42.9

71.4

2

28.6

28.6

100.0

7

100.0

100.0

strongly agree
Total

Question four states: I have a good understanding of the Centers for Disease Control
(CDC) guidelines (2016) on managing CNMP. The Wilcoxon Signed-Ranks Test indicated that
post-test ranks were statistically significantly higher than the pre-test ranks (Z=21.000, p=.023)
for question four which indicates the participants’ understanding of the CDC guidelines for
management CNMP improved after the intervention (Table 16: Wilcoxon Question 4).
Descriptive statistical analysis of pre-test scores indicated that 14.3% strong disagreed
that they had a good understanding of the CDC guidelines, 57.1% were uncertain, and 28.6%
agreed they had a good understanding of the CDC guidelines for managing chronic pain in
primary care (Table 17: Pre-test Question 4). Descriptive statistical analysis of post-test scores
revealed 14.3% were uncertain if they had a good understanding of the CDC guidelines, 57.1%
agreed they had a good understanding of the guidelines and 28.6% strongly agreed (Table 18:
Post-test Question 4).
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Table 16: Wilcoxon Question 4
I have a good understanding of the Centers for Disease Control (CDC) guidelines (2016) on
managing CNMP.
Related - Samples Wilcoxon Signed Rank Test
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7

Total N
Test Statistic

2 1.000

Standard Error

4 .623

Standardized Test Statistic

2 .271

Asymptotic Sig. (2 - sided test)

.023

Table 17: Pre-test Question 4
I have a good understanding of the Centers for Disease Control (CDC) guidelines (2016) on
managing CNMP.

Frequency
Valid

Percent

Valid Percent

Cumulative
Percent

strongly disagree

1

14.3

14.3

14.3

uncertain
agree

4
2

57.1
28.6

57.1
28.6

71.4
100.0
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Total
Table 18: Post-test Question 4

7
100.0
Pre-test question 4

100.0

I have a good understanding of the Centers for Disease Control (CDC) guidelines (2016) on
managing CNMP.
Post-test question 4

Valid

uncertain
agree

Frequency
1

Percent
14.3

Valid Percent
14.3

Cumulative
Percent
14.3

4

57.1

57.1

71.4

2

28.6

28.6

100.0

7

100.0

100.0

strongly agree
Total

Question five states: I am comfortable with where to find the CDC guidelines (2016).
The Wilcoxon Signed-Ranks Test indicated that post-test ranks were not statistically
significantly higher than the pre-test ranks (Z=10.000, p=.059) for question five which indicates
there was no difference in the participants comfort levels in finding the CDC guidelines after the
intervention (Table 19: Wilcoxon Question 5).
Descriptive statistical analysis of pre-test scores revealed 14.3% disagree, which means they are
not comfortable with where to find the CDC guidelines, 87.5% agreed they are comfortable with
where to find the CDC guidelines (Table 20: Pre-test Question 5). Descriptive statistical analysis
of post-test scores indicated 57.1% agreed and 42.9% strongly agreed that they were comfortable
with where to find the CDC guidelines (Table 21: Post-test Question 5). Although the difference
between the pre- and post-test scores was not statistically significant, there was still positive
improvement from a clinical perspective.
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Table 19: Wilcoxon Question 5
I am comfortable with where to find the CDC guidelines (2016).
Related - Samoles Wilcoxon Sianed Rank Test
oPositivt Dlfftrtncts
(N - 4)
■ NtgativtDifftrtncts

(N- 0)
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Pos nu t q uu 1io n S - Prt tu 1 q uu 1ionS

Total N
Tes t Statistic

10.000

Standard Error

2.646

Standardized Tes t Statis tic

1. 890

As ymptotic Sig. (2 -sided te s t)

.059

Table 20: Pre-test Question 5
I am comfortable with where to find the CDC guidelines (2016).
Pre-test question 5
Frequency
Valid

disagree

Percent

Valid Percent

Cumulative
Percent

1

14.3

14.3

14.3

agree

6

85.7

85.7

100.0

Total

7

100.0

100.0

Table 21: Post-test Question 5
I am comfortable with where to find the CDC guidelines (2016).
Post-test question 5

Valid

agree
strongly agree
Total

Frequency
4

Percent Valid Percent
57.1
57.1

3

42.9

42.9

7

100.0

100.0

Cumulative
Percent
57.1
100.0
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Question six states: I have a sense of satisfaction when managing CNMP. The Wilcoxon
Signed-Ranks Test indicated that post-test ranks were statistically significantly higher than the
pre-test ranks (Z=15.000, p=.038) for question six which indicates the participants sense of
satisfaction when managing CNMP improved after the intervention (Table 22: Wilcoxon
Question 6).
Descriptive statistical analysis of pre-test scores indicated 14.3% strongly disagreed that
they felt a sense of satisfaction when managing CNMP, 71.4% disagreed, and 14.3% were
uncertain if they had a sense of satisfaction when managing CNMP (Table 23: Pre-test Question
6). Descriptive statistical analysis of post-test scores displayed 28.6% disagreed that they felt a
sense of satisfaction when managing CNMP, 42.9% were uncertain, and 28.6% agreed they had
a sense of satisfaction when managing CNMP (Table 24: Post-test Question 6).

Table 22: Wilcoxon Question 6
I have a sense of satisfaction when managing CNMP.

3.0

Related - Samoles Wilcoxon Sianed Ran k Test
0 Posittve Differences

{N• S)
■ Ne93tive Diffl!rencM
{Na O)

(Number of Ties • 2)

LO

0 .0
.0 0

.50
1.00
l.S0
2.00
2.S0
Posnut quu tion 6 - Pr" t1est quu tion 6

3.00

Total N

Test St.1tis tic

15.000

Standard Error

3.623

Standardized Test Statistic

2.070

Asymptotic Sig. (2 - sid ed test)

.038
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Table 23: Pre-test Question 6
Pre-test question: I have a sense of satisfaction when managing CNMP.
Pre-test question 6
Frequency
Valid

strongly disagree

Percent

Valid Percent

Cumulative
Percent

1

14.3

14.3

14.3

disagree

5

71.4

71.4

85.7

uncertain

1

14.3

14.3

100.0

Total

7

100.0

100.0

Table 24: Post-test Question 6
I have a sense of satisfaction when managing CNMP.
Post-test question 6

Valid

Frequency
2

Percent
28.6

Valid Percent
28.6

Cumulative
Percent
28.6

3

42.9

42.9

71.4

agree

2

28.6

28.6

100.0

Total

7

100.0

100.0

disagree
uncertain

Question seven states: My CNMP patients are satisfied with the treatment they receive
from me. The Wilcoxon Signed-Ranks Test indicated that post-test ranks were statistically
significantly higher than the pre-test ranks (Z=10.000, p=.046) for question seven which
indicates the participants felt their patient’s satisfaction with their treatment for CNMP improved
after the intervention (Table 25: Wilcoxon Question 7).
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Descriptive statistical analysis of pre-test scores revealed 14.3% disagreed that their
patients are satisfied with the treatment they receive, 71.4% were uncertain, and 14.3% agreed
their patients are satisfied with the treatment they receive (Table 26: Pre-test Question
7). Descriptive statistical analysis of post-test scores indicated 42.9% were uncertain and 57.1%
agree their CNMP patients are satisfied with the treatment they receive (Table 27: Post-test
Question 7).
Table 25: Wilcoxon Question 7
My CNMP patients are satisfied with the treatment they receive from me.
Related - Samples Wilcoxon Signed Rank Test

~------,Of~!~~e Differences

4.0-

■ ~N'2Mive Differences
(Number of Ties .. 3}

J o + - - - - ---<

!i2.0
l.0-

o.o+---~----+---~------<
.00

Poi;ttutquei tion 7- Pretutquution 7

Total N
Test Statistic

10 .000

Standard Error

2.500

Standardized Test Statistic

2.000

Asymptotic Sig. (2-sided test)

.046

Table 26: Pre-test Question 7
My CNMP patients are satisfied with the treatment they receive from me.
Pre-test question 7

Valid

disagree
uncertain
agree
Total

Frequency
1

Percent
14.3

Valid Percent
14.3

Cumulative
Percent
14.3

5

71.4

71.4

85.7

1
7

14.3
100.0

14.3
100.0

100.0

40

Table 27: Post-test Question 7
My CNMP patients are satisfied with the treatment they receive from me.
Post-test question 7
Frequency
Valid

Percent

Valid Percent

Cumulative
Percent

uncertain

3

42.9

42.9

42.9

agree
Total

4
7

57.1
100.0

57.1
100.0

100.0

There were seven items on the post-test that were not included on the pre-test. These
items were directly related to the CDC education module and the step model. Since these were
not paired items, descriptive statistics were used to analyze the data.
Post-test item eight states: the step model increased my understanding of treating CNMP.
85.7% agreed and 14.3% strongly agreed with this statement (Table 28: Post-test Question
8). Post-test item nine states: The CDC education modules increased my understanding of
opioids. 71.4% agree and 28.6% strongly agree with this statement (Table 29: Post-test Question
9). Post-test item ten states: The CDC education modules increased my understanding of the
CDC guidelines. 71.4% agree and 28.6% strongly agree with this statement (Table 30: Post-test
Question 10). Post-test item 11 states: I referred to the step model for guidance when treating
patients with CNMP. 28.6% were uncertain, 57.1% agreed, and 14.3% strongly agreed with this
statement (Table 31: Post-test Question 11). Post-test item 12 states: The step model helped me
when treating patients with CNMP. 28.6% of the participants were uncertain and 71.4% agreed
with this statement (Table 32: Post-test Question 12). Post-test item 13 states: I would
recommend the step model to my colleagues. 71.4% of the participants agreed and 28.6%
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strongly agreed (Table 33: Post-test Question 13). Finally, post-test item 14 states: I would
recommend the CDC education modules to my colleagues. 57.1% of the participants agreed and
42.9% strongly agreed (Table 34: Post-test Question 14). Overall the feedback from the
participants about the step model and the education modules was positive indicating they were
helpful.
Table 28: Post-test Question 8
The step model increased my understanding of treating CNMP.
Post-test question 8

Valid

agree
strongly agree

Frequency
6

Percent
85.7

Valid Percent
85.7

Cumulative
Percent
85.7

1

14.3

14.3

100.0

7

100.0

100.0

Total
Table 29: Post-test Question 9

The CDC education modules increased my understanding of opioids.

Valid agree
strongly
agree
Total

Post-test question 9
Frequenc
Valid
Cumulative
y
Percent
Percent
Percent
5
71.4
71.4
71.4
2

28.6

28.6

7

100.0

100.0

100.0
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Table 30: Post-test Question 10
The CDC education modules increased my understanding of the CDC guidelines.

Valid agree
strongly
agree
Total

Post-test question 10
Frequenc
Valid
Cumulative
y
Percent
Percent
Percent
5
71.4
71.4
71.4
2

28.6

28.6

7

100.0

100.0

100.0

Table 31: Post-test Question 11
I referred to the step model for guidance when treating patients with CNMP.
Post-test question 11
Frequency
Valid

Percent

Cumulative
Percent

Valid Percent

uncertain

2

28.6

28.6

28.6

agree

4

57.1

57.1

85.7

1

14.3

14.3

100.0

7

100.0

100.0

strongly agree
Total
Table 32: Post-test Question 12

The step model helped me when treating patients with CNMP.
Post-test question 12
Frequency
Valid

uncertain

Percent

Valid Percent

Cumulative
Percent

2

28.6

28.6

28.6

agree

5

71.4

71.4

100.0

Total

7

100.0

100.0
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Table 33: Post-test Question 13
I would recommend the step model to my colleagues.
Post-test question 13

Valid

agree
strongly agree

Frequency
5

Total

Percent
Valid Percent
71.4
71.4

2

28.6

28.6

7

100.0

100.0

Cumulative
Percent
71.4
100.0

Table 34: Post-test Question 14
I would recommend the CDC education modules to my colleagues.

Valid agree
strongly
agree
Total

Post-test question 14
Frequenc
Valid
Cumulative
y
Percent
Percent
Percent
4
57.1
57.1
57.1
3

42.9

42.9

7

100.0

100.0

100.0

Descriptive statistics were used to analyze the true/false items. Items one through seven
were on both the pre- and post-test. Items eight and nine were only on the post-test since they
only pertained to the intervention. There was minimal change in the overall prescribing habits of
the sample providers as measured with the true/false questions.
The most significant items on this portion of the questionnaire were the responses for
items seven through nine. Item seven states, I use the CDC guidelines (2016) for CNMP. The
pre-test scores indicated that 42.9% of the participants used the CDC guidelines and 57.1% did
not use the CDC guidelines before the intervention. After the intervention all of the participants
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used the guideline, 100% (Table 35: Pre-test Use CDC Guidelines, Table 36: Post-test Use CDC
Guidelines, Table 37: Pre-test Use CDC Guidelines Bar Chart, Table 38: Post-test Use CDC
Guidelines Bar Chart). Item eight states: the step model helped me treat patients with
CNMP. All of the participants felt the step model helped them treat CNMP (Table 39: Post-test
Step Model Useful). Finally, item nine reads: the CDC education modules (2017) helped me treat
patients with CNMP. Again, all of the participants felt the education modules helped them when
treating CNMP (Table 40: Post-test Education Module Useful).
Table 35: Pre-test Use CDC Guidelines
Pre-CDC guidelines
Frequenc
Valid
Cumulative
y
Percent
Percent
Percent
Valid true
3
42.9
42.9
42.9
false
4
57.1
57.1
100.0
Total
7
100.0
100.0
Table 36: Post-test use CDC guidelines

Valid true

Post-CDC guidelines
Frequenc
Valid
Cumulative
y
Percent
Percent
Percent
7
100.0
100.0
100.0
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Table 37: Pre-test use CDC Guidelines Bar Chart
Pre- CDC guidelines
60
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40

c
"'~

cf!

30

20

10

true

fal~e

Pre-CDC guidelines

Table 38 Post-test use CDC Guidelines Bar Chart
Post - CDC guidelines
100-

80-

60-

4 0-

20-
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t rue

Post - CDC guldellnes
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Table 39 Post-test Step Model Useful
Step model

Valid true

Frequenc
y
Percent
7
100.0

Valid
Cumulative
Percent
Percent
100.0
100.0

Table 40 Post-test Education Modules Useful

Valid true

Education module
Frequenc
Valid
Cumulative
y
Percent
Percent
Percent
7
100.0
100.0
100.0

The final analysis of the project data suggests the education module and step model
increased knowledge and confidence in managing CNMP and prescribing opioid medication for
this population. It also demonstrated a lack of education related to management of CNMP and
opioid medications highlighting the need for increased education on chronic pain management
and opioid therapy for physicians in the sample population.
The step model developed for this project was helpful as a visual representation of the
CDC guidelines on prescribing opioids for chronic pain in the primary care setting for the sample
population. This project exhibited the benefit of having a tool that is easily accessible and easily
comprehended which could help with evidenced based management of chronic pain.
The mission of this project was to provide education and easily accessible and
comprehensible guidance for primary care providers in managing chronic, non-cancer pain
utilizing the updated CDC guidelines. Although there was a small sample, the results suggest the
mission was achieved.
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The vision of the project was to improve provider satisfaction in caring for patients with
chronic, non-cancer pain as well as improving patient outcomes by utilizing best practices. The
results of the project support the vision for this project was achieved.
Limitations
There were several limitations noted for this study. The first, and probably most
significant, is the small sample size. The project materials were given to 22 primary care
providers with only seven returned. Additionally, the study was conducted only in the Centura
Health System, north metro Denver area. The homogeneity of the sample group may not
account for factors that could change the outcomes. The study is not transferable to other
locations based on the small sample size.
Additionally, there were no nurse practitioners who returned the project materials for
analysis. The homogeneity of the sample does not allow for generalization to all primary care
providers. Finally, due to the academic nature of this project, time constraints for data collection
limited the number of participants. A repeat study with a larger sample population and more
participants might produce stronger data for practice improvement.
Recommendations
Repeating the study with at least 50% nurse practitioners or even, 100% nurse
practitioners could highlight the potential educational gap in nurse practitioner programs. While
the data indicated statistically significant improvement in several areas in the sample population,
the results cannot be generalized to all primary care providers. Additional research about the
utilization of the Step Model is recommended. Additionally, a larger recruitment area could
increase heterogeneity and therefore allow for increased reliability and adaptability of the
model.
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Implications for Change
Further studies might elicit more information from providers on personal prescribing
habits to account for factors influencing prescribing other than knowledge and confidence plus
what role the lack of knowledge and confidence of the providers plays in the current opioid
crisis. Determining if primary care providers are indeed prescribing opioids inappropriately will
be difficult due to the lack of agreed upon guidelines, subjective nature of chronic pain, and
personal philosophy. Prescribing is largely based on individual clinical decision making.
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Appendix B
Timeline

Pro1«t o~efopment

-

PrOJK1 mp&cmC'nl~IIOll

Development: July 2016 to May 2017
IRB Submission: September 2017 to November 2017
Implementation: December 2017 to February 2018
Data Analysis: March 2018
Disseminate Findings: April 2018
Defense of Project: April 2018
Dissemination to Library: April 2018
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Appendix C
Budget

Cost Category

Description

Time spent on surveys
Primary Care Providers
and education module
(Based on goal of 20
at $SO/hour (2-hour
participants)
average).
Time spent designing
project and education
module and data
Project Researchers
analysis at $SO/hour
(approximately 200
hours) .
Step model and
Printing Costs
questionnaires @
0.10/page
Statistical analysis
SPSS
software
To keep
Storage Box
questionnaires locked
Data analysis at
Statistician
approximately
$SO/hour for 3 hou rs

Total Cost

$2,000.00

$10,000.00

Est. $50.00
$60.00
Est. $50.00
Est. $150.00
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Appendix D
CDC Education Modules

Addressing the Opioid Epidemic: Recommendations from CDC
WB2857

Module1

PROGRAM DESCRIPTION: This module will look at the CDC recommendations
regarding the prescription of opioids for chronic pain. Given that it is sometimes hard to
determine when acute pain becomes chronic pain, recommendations are also ilduded
related to prescribilg opioids for acute pain. You will have the opportunity to examine
the implications of these recommendations for treating your patients, and to practice
making the best choices for their overall health and well-being.
Please refer to the CDC Guidelne for PrescrlJing Opioids for Chronic Pain for additional
ilformation as needed during this training.
OBJECTIVES:
At the condusion of the session, the participant will be able to:

1) Explain why a guideline for prescribing opioids is needed
2) Describe the key recommendations in the CDC guideline for prescribing opioids
3) Explain potential benefits of implementing the CDC recommendations for prescribilg
opioids
FACULTY/ CREDENTIALS:
Deborah Dowell, MD, MPH
Senior Medical Advisor, Division of Unintentional Injury Prevention
National Center for Injury Prevention and Control (NCIPC)
Centers for Disease Control and Prevention (CDC)
Office of Noncommunicable Diseases, Injury and Environmental Health (ONDIEH)
Debra Houry, MD, MPH
Director
National Center for Injury Prevention and Control (NCIPC)
Centers for Disease Control and Prevention (CDC)
Office of Noncommunicable Diseases, Injury and Environmental Health (ONDIEH)
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Treating Chronic Pain Without Opioids
WB2859
Module2

PROGRAM DESCRIPTION: This module will look at the CDC recommended options
for treating chronic pain without opioids. You \Nill have the opportunity to examine the
benefits and expected outcomes of prescribing nonopioid medications and
nonpharmacologic treatments to your patients.
Please refer to the CDC Guideline for Prescribing Opioids for Chronic Pain for additional
information as needed during this training.

OBJECTIVES:
At the conclusion of the session, the participant will be able to:

1) Recognize that nonopioid medications and nonpharmacologic treatments are the
preferred methods for treating chronic pain
2) Describe co1TTI1unication techniques that facilitate a patient-centered approach to
manage chronic pain
3) Describe risks and benefits of first-line treatments for chronic pain
4) Identify nonopioid medications for various types of chronic pain
5) Identify nonpharrnacologic treatment options for various types of chronic pain

FACULTY/ CREDENTIALS:
Deborah Dowell, MD, MPH
Senior Medical Advisor, Division of Unintentional Injury Prevention
National Center for Injury Prevention and Control (NaPC)
Centers for Disease Control and Prevention (CDC)
Office of Noncommunicable Diseases, Injury and Environmental Health (ONDIEH)
ORIGINATION DATE:
EXPIRATION DATE:

August 4, 2017
August 4, 2019

URL:

https1/www.cdc.gov/drugoverdose/training/nonopioid

HARDWARE/SOFlWARE:

Computer Hardware; Internet connection; Browser
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Appendix E
CDC Response to Step Model

From:
Subject:
Date:
To:

Dow ell, Deborah (Debbie) (CDC/ONDIEH/NCIPC) gdo7@cdcgov
RE: Research question
November 17, 2017 at 9:06 AM
Smith, Melissa J msmIth036@regIs edu

Hi Melissa ,
Sorry for my long delay in responding to this. I rece ived your voicemail earlier this week.
I think the step model you sent makes sense and has value. It also fa irly accu rately
reflects the recommendations in the 2016 CDC Guideline for Prescribing Opioids for
Chronic Pain. There are just 2 modifications I'd suggest if you want it to align more
completely w ith CDC's Guideline:
I. We did not specifically state that patients on :::. 90 MME/day of opio ids needed to
be referred to a pain special ist, although we suggested it as a consideration.
Other guidelines have made a stronger recommendation on this, and we
considered it, but we decided not to because of concerns about inadequate
access to pain specialists in many areas and because it would not be certain that
every pain specialist would always carefully evaluate benefits and risks consistent
w ith the evidence summarized in the Guideline. Instead, we recommended
avoiding or carefully justifying increasing opioid dosage to 90 MME or more. We
noted that justification could include the following facto rs: "indi viduali zed assessment
of benefits and risks and wei ghing factors such as di agnosis, incremental benefits for pain
and function relati ve to harms as dosages approach 90 M:ME/day, other treatments and
effectiveness, and recommendati ons based on consul tation wi th pain specialists". For
patients already rece iving high dosages of opio ids, we recommended that "patients
should be offered the opportuni ty to re-evaluate their continued use of opioids at hi gh
dosages in light of recent evidence regarding the association of opi oid dosage and
overdose risk. Clinici ans should explain in a nonj udgmental manner to patients already
taking high opioid dosages (::::90 M:ME/day) that there is now an established body of
scientific evidence showing that overdose ri sk i s increased at hi gher opioid dosages.
Clinici ans should empathically review benefits and risks of continued high-dosage opioid
therapy and should offer to work w ith the patient to taper opioids to safer dosages. For
patients who agree to taper opioids to lower dosages, clini cians should collaborate with the
patient on a tapering pl an."
2. This is a very m inor point, but we d id not includ e massage in recommended
nonopioid treatments for pain in the Guideline, because we did not find studies
documenting long-term efficacy. However, it is very unlikely that massage will
harm patients and it may help some, so I think reasonable to include among
suggested approaches.
Thank you for undertaking this important work!
Best wishes,
Debbie
Debora h Dowell, MD, M PH
C DR, US Pub lic Health Service
Senior Me dical Advisor, Division of Unintentional Injury Preventio n
CDC - National Center for Injury Prevention and Control
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Appendix F
Conceptual Model

Logic Model Development
Program Planning Template
Strategies

Assumptions

5

The hospital and primary care providers will support efforts to improve patient
care, increase provider knowledge and confidence, and reduce opioid burden in
the community by a reduction in inappropriate prescribing practices.
Primary care providers will agree to participate in education of step model.

Create a step model for managing chronic pain patients in the primary care
setting.

•

Create an online learning video to instruct primary care providers how to use
the model and how and when to prescribe opioids safely.

lnfluentlal Factors

Access to primary care
providers through hospital
network..
Primary care providers are
fearful of patient harm and
scrutiny from regulatory
agencies, knowledge gaps,
and Jack formal medical
training to prepare them to
manage chronic pain
effectively.
Primary care providers lack
of willingness to devote
time to learning step model.

4

•

Increasing knowledge and confidence of primary care providers in chronic pain
management will improve patient outcomes, increase provider satisfaction, and
reduce opioid burden in the community.

Problem or Issue

Desired Results
(outputs, outcomes,
and Im act

Lack of knowledge and confidence in managing chronic
pain patients by primary care providers.
Patients are not treated for chronic pain according to
guidelines and best practice, especially when prescribing
opioids.
Patients have untreated or undertreated chronic pain.
Primary care providers experience less job satisfaction.

Increased knowledge and
confidence in managing
chronic pain patients by
primary care providers.
Improved patient outcomes
by using step model.
Reduction in inappropriate
prescribing of opioids for
chronic pain.
Reduction in overall pill
burden in community.

Community Needs/Assets
•
Colorado is second highest in country for nonmedical use
of prescription opioids.
Patients are treated inappropriately, increasing potential or
misuse or abuse of opioids.
Inappropriate prescribing of opioids contributes to the
current opioid epidemic.

Evaluation Logic Model Guide, W.K. Kellogg Foundation, Page 57

Appendix G

6

Primary care providers
experience increased job
satisfaction.

3
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Regis University IRB Exempt Letter

REGIS~UNIVERSITY
REGIS .EDU
Institutional Review Board
DATE:

October 17, 2017

TO:
FROM:

Melissa Smith, MSN
Regis University Human Subjects IRB

PROJECT TITLE:
SUBMISSION TYPE:

[1121681-1] Step model for managing chronic, non-cancer pain in primary
care
New Project

ACTION :
DECISION DATE:
REVIEW CATEGORY:

DETERMINATION OF EXEMPT STATUS
October 17, 2017
Exemption category # (7)

Thank you for your submission of New Project materials for this project. The Regis University Human
Subjects IRB has determined this project is EXEMPT FROM IRB REVIEW according to federal
regulations 45.CFR46.101 (b).
We will retain a copy of this correspondence within our records.
If you have any questions, please contact the Institutional Review Board at im@regis.edu. Please include
your project title and reference number in all correspondence with this committee.

This letter has been electronically signed in accordance with all applicable regulations, and a copy is retained within Regis University
Human Subjects IRB's records.
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Appendix H
Catholic Health Initiatives (CHI) IRB Exempt Letter

...

""r CHI Institute for

FWA Number: FWA 00019514
OHRP IRB Number: IRB00009715

Research and Innovation

DATE :

December 5, 2017

T O:

Melissa Sm ith , DNPc

PROJECT TITLE :

[1146024-1] Step mod el for manag ing chron ic, non-cancer pain in primary
care
New Project

SUBMISSIO N TYPE:
ACTION :

DETERMINATION OF EXEMPT STATUS

DECISION DATE :

November 27 , 2017

REVI EW TYP E:
REVI EW CATEGORY:

Exempt Review
Exemption category # 1, 2

Thank you for your submission to the Catholic Health Initiatives Institute for Research and Innovation
Institutional Review Board (CHIRB). An individual designated by the CHIRB detennined this project to be
EXEMPT FROM IRB REVIEW according to lederal regulations. The following documents were reviewed
in making this detennination of exemption:
• AbstracUSummary - MelissaSmithFCOIDisclosure (UPDATED: 10/21/2017)
• AbstracUSummary - IRBnet Exempt Approval.pdf (UPDATED: 10/21/2017)
• AbstracUSummary -Adult lnfonned Consent Fonn Centura.docx (UPDATED: 10/21/2017)
• AbstracUSummary- Recruitment Flyer Final.pdf (UPDATED: 10/21/2017)
• AbstracUSummary-CDC training video module 1.pdf(UPDATED: 10/21/2017)
• AbstracUSummary - CDC training video module 2.pdf (UPDATED: 10/21/2017)
• AbstracUSummary- Pre-Test Questions Final.docx (UPDATED: 10/21/2017)
• AbstracUSummary - Post Test Questions final.docx (UPDATED: 10/21/2017)
• AbstracUSummary - Centura Approval.pdf (UPDATED: 10/21/2017)
• Advertisement- CHIRB lnfonnation Sheet - Recruitment Script v. "ll FEB 2015.docx (UPDATED:
10/21/2017)
• AmendmenUModification - Dowell Response PDF.pdf (UPDATED: 11/26/2017)
• AmendmenUModification -Appendix C Step Model 1.4 PDF.pdf (UPDATED: 11/26/2017)
• Application Form - Expedited Regis University Application (UPDATED: 10/21/2017)
• CHI - Research Application -CHI - Research Application (UPDATED: 10/21/2017)
Should you wish to amend this project in any way that might impact this exempt determination, please
contact the CHIRB. Please note that all personnel who will interact with research subjects or access
identifiable data wil need to have completed HIPAA and human subject protection courses as specified in
the CIRI Research Education Plan prior to initiating research activities. For assistance, contact the CHIRB
or the CIRI Training Manager. Please also note that the Pl must maintain documentation of all required
personnel trainings, and understands that training records, among other study documents, are auditable.

- 1-
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Appendix I
CITI Certifications

1~CITI

Completion Date 21-Aug-2017
Expiration Date 20-Aug-2020
24256766
Record JO

,~ PROGRAM
This is to certify that:

Melissa Smith
Has completed the following CITI PfOgram course:
The RCR for Social & Behavioral (Curriculum Group)
The RCR for Social & Behavioral (Course Leam er Group)
1 - RCR
(Stil&el

CITI

Under requirements set by:

Regis University

Verify at V\WW.citiprogram.org/verifyf'w93c7e529-d214-43e0-aac4-0ec4d06Sb224-24256766

~CITI
~ PROGRAM

Completion Date 21-Aug-2017
NIA
Expiration Date
Record JO
24256769

This is to certify that:

Melissa Smith
Has completed the following CITI Program course:

Information Privacy & Security

(Currkulum Group)

Researche,rs (IPS)

{C"Olir<.I" 1 P.lrnerGroup)

1 ~ Basic Course
Under rcquircmcnt5 set by:

Regis University

CI

,r,
,.

Collabor~rive, lf!srnut:onal Tra1nt:1g 1n:ti.Jtive

verify at www. citiprogram.org/verify/?w1 a331 a 19 -57a8-400a-8379-aea6c426c532- 24256769
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-1CITI
"

Completion Date 21-Aug-2017
Expiration Date 20-Aug-2020

Record 1D

24256765

PROGRAM

This is to certify that:

Melissa Smith
Has completed the followi ng CITI Program course:
1cumcutumGl"oup)
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(St.1geJ
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Regis University
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(CourH LHr n«Group)

2 - Refresher Course
Under requirements set by:
Catholic Health Initiatives

Verify a t www.citiprogram.org/ verify/?wl 273e73 l-9fl f-4d6b-b4bd-c1 969febbb6d-2445960 7

24459607
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.t~CITI

~

Completion Date 04-Sep-201 7
Expiration Date 03-Sep-2021

Record 10

24459609

PROGRAM

This is to certify that:

Melissa Smith
Has completed the following CITI Program course:
CITI Conflicts of Interest (Curriculum Group)

Conflicts of Interest

(CourseLearMrGroup)

1 - Stage 1

(Sta5e)

Under requirements set by:

Catholic Health Initiatives

CITI

Verify at www.citiprogram.org/verifyl?wb3e4c571 -3ab0-49f4-a 1ec-f8df316a8f 15-24459609

.t~CITI
~

Completion Date 04-Sep-2017
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24459606
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PROGRAM
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Responsible Conduct of Research (RCR)
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Social-Behavioral -Educational Researchers (RCR) (Course- Le.irner Group)
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Collabora:Ne 1nst1tut10.1.1I Training In uotive

Verify at www.ctiprogram.org/verifyf'w94effe07-e52d-4f33-adf3-437f6b99a4e5•24459606
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Appendix J
Pre-test Questionnaire

Pre-test Questions
Code mnnber:

INSTRUCilONS: Please ra1e bow strongly you agree or disagree with each of the following statements by
circling the appropriate number.

2disagree

3- lJIICertain

4- agree

5strongly
agree

D1

D2

03

04

Os

□1

□2

03

04

Os

1strongly
disagree

1. I have sufficient knowledge

to manage chronic, nonmalignant pain (CNMP) in
my primary care practice.

2. I have access to education
regarding how to manage
opioim for CNMP.

3.

I have confidence in my
ability to manage CNMP in
primary care.

□1

□2

03

04

Os

4.

I have a good understanding
of the Centers for Disease
Control (CDC) guidelines
(2016) on managing CNMP.

D1

D2

03

04

Os

D1

D2

03

04

Os

□1

□2

03

04

Os

D1

D2

03

04

Os

5. I am comfortable with where
to find the CDC guidelines

(2016).
6. I have a sense of satis:laction
when managing CNMP.

7. My CNMP patients are
satisfied with the treatment
they receive from me.

Continued on next page
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INSTRUCTIONS: Read each statement. Circle true if the statement applies to your practice or false if the
statement does not apply to your practice_

L I prescribe opioids for CNMP_

□True

□False

2_ I prescribe :'.S 50 morphine milligram equivalents (MME) per day for
CNMP_

□True

□False

3_ I prescribe between 50 MME and :'.S 90 MME per day for CNMP_

□True

□False

4_ I prescribe > 90 MME per day for CNMP_

□True

□False

5_ I prescribe non-opioid medications for CNMP_

□True

□False

6 _ I prescribe multidisciplinary interventions for CNMP_

□True

□False

7_ I use the <DC guidelines {2016) for CNMP_

[Jrrue

□False

Comments:
Please describe your unique attitude toward managing the chronic pain patient in the primary care setting_

Please check your educational preparation: D MD
Age range: D21-30
Gender: Dmale

D 31-40

□female

D41-50

D Resident D NP

051-60

061-70

OPA
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Appendix K
Post-test Questionnaire

Post-test Questions
Code number:
INSTRUCTIONS: Please rate how strongly you agree or disagree with each ofthe following statements by
circling the appropriate number.

1strongly
disagree

2disagree

3 - uncertain

4 - agree

strongly
ae.ree

01

02

03

04

05

2. I have access to education
regarding how to manage
opioids for CNMP _

01

02

03

04

05

3. I have confidence in my
ability to manage CNMP in
primary care.

01

02

03

04

05

4. I have a good understanding
of the Centers for Disease
Control (CDC) guidelines on
managing CNMP (2016).

01

02

03

04

05

01

02

03

04

05

6. I have a sense of satisfilction
when managing CNMP.

01

Oz

03

04

05

7. My CNMP patients are
satisfied with the treatment
they receive from me.

01

02

03

04

05

8. The step model increased my
understanding of treating
CNMP.

01

02

03

04

05

9. The CDC education modules
(2017) increased my
understanding of opioids.

01

02

03

04

05

10. The CDC education modules
(2017) increased my
understanding of the CDC
guidelines (2016).

01

02

03

04

05

11. I referred to the step model
for guidance when treating
patients with CNMP_

01

02

03

04

05

5-

1. I have sufficient knowledge

to manage chronic, nonmalignant pain (CNMP) in
my primary care practice.

5. I am comfortable with where
to find the CDC guidelines
(2016).
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12. The step model helped me
when treating patients with

01

02

03

04

□5

13. I would recommend the step
model to my colleagues.

D1

02

03

04

□5

14. I would recommend the COC
education modules {2017) to
my colleagues.

D1

02

03

04

□5

CNMP.

INSTRUCTIONS: Read each statement. Circle true if the statement applies to your practice or false if the
statement does not apply to your practice.

L I prescribe opioids for CNMP.

□True

0False

2. I prescribe :S 50 morphine milligram equivalents (MME) per day for

□True

□False

3. I prescribe between 50 MME and :S 90 MME per day for CNMP.

□True

0False

4. I prescribe > 90 MME per day for CNMP.

□True

□False

5. I prescribe non-opioid medications for CNMP.

□True

□False

6. I prescribe multidisciplinary interventions for CNMP.

□True

□False

7. I use the COC guidelines (2016) for CNMP.

□True

□False

8. The step model helped me treat patients with CNMP.

□True

0False

9. The CDC education modules (2017) helped me treat patients with
CNMP.

□True

□False

CNMP.
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Comments:

Please describe your unique attitude toward managing the chronic pain patient in the primary care setting has or
has not changed since completing the education modules.

Please describe your unique attitude toward managing the chronic pain patient in the primary care setting has or
has not changed since using the step model or why not using.

Please check your educational preparation: D MD
Age range: D21-30
Gender: Dmale

D 31-40

□female

D 41-50

D Resident D NP

051-60

0 61-70

0 PA
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Appendix L
Data Dictionary
Table

Field

Data Type

Provider

Provider

PROVIDER_ID

Integer

Provider

PROVIDER_TYPE

Integer

Age Range

AGE

Integer

Pre-Test

Pre-Test

PREQUESTION_1 - 7

Integer

Pre-Test

PREQUESTION_1-7

Category

Pre-Test

PREQUESTION_COMMENT

Text

Description
Include MD,
Resident, NP, or
PA currently
practicing in the
primary care
setting in the
Centura Hospital
System.
Unique number
given to each
provider.
A unique ID for
each specialty:1MD, 2-Resident,
3-NP or 4-PA.
Age range: 1- 2130; 2- 31-40; 341-50; 4- 51-60; 561-70
A Likert-scale test
and true/false
questions to be
administered
before the
education module
and introduction to
step-model.
A unique response
for each question
numbered 1-7 for
each provider.
True/false
response for each
question numbered
1-7 for each
provider.
An open-ended
question to allow
for the participant
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to describe their
unique attitudes
toward managing
the chronic pain
patient in the
primary care
setting.
Post-Test

Post-Test

POSTQUESTION_1-14

Integer

Post-Test

PostQUESTION_1-9

Category

Post-Test

POSTQUESTION_COMMENT Text

A Likert-scale test
and true/false
questions to be
administered after
the education
module and
introduction to
step-model.
A unique response
for each question
number 1-14 for
each provider.
True/false
response for each
question numbered
1-9 for each
provider.
An open-ended
question to allow
for the participant
to describe their
unique attitudes
toward managing
the chronic pain
patient in the
primary care
setting.
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Appendix M
Recruitment Flyer

A doctoral project practice improvement study for the management of
chronic, non-cancer pain in primary care practice

The benefits of
participation are:
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C -

Increasing your knowledge
concerning managing chronic,
non-cancer pain.

•

Increased knowledge and
understanding of the CDC
guidelines for opioid prescribing.

•

Earn CME cred its with completion
of the online learning module.
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Risks of participation:
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If you are interested in participating or
would like more information regarding
this study please contact the researcher,
Melissa Smith, DNPc via phone or email
at:
msmith036@regis.edu
or 317-664-1998

